Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
weaker decrease » greater decrease (Expand Search), water decreases (Expand Search)
decrease costs » increased costs (Expand Search), decreased across (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
Showing 121 - 140 results of 2,480 for search '(( significantly ((weaker decrease) OR (teer decrease)) ) OR ( significant decrease costs ))', query time: 0.29s Refine Results
  1. 121
    Relative percent change in billing charges related to medical use (2019 vs 2020).

    Relative percent change in billing charges related to medical use (2019 vs 2020). by Jinah Sim (15140709)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 122
    Forecasts of cancer patients’ medical use (cancer type/cases).

    Forecasts of cancer patients’ medical use (cancer type/cases). by Jinah Sim (15140709)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 123
    Forecasts of cancer patients’ medical use (age/admission cases).

    Forecasts of cancer patients’ medical use (age/admission cases). by Jinah Sim (15140709)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 124
    The effect of utilization due the characters of cancer patients (income).

    The effect of utilization due the characters of cancer patients (income). by Jinah Sim (15140709)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 125
    The effect of utilization due the characters of cancer patients (age).

    The effect of utilization due the characters of cancer patients (age). by Jinah Sim (15140709)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 126
    Forecast of medical resource use and expenditures among cancer patients (2019 vs 2020).

    Forecast of medical resource use and expenditures among cancer patients (2019 vs 2020). by Jinah Sim (15140709)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 127
    Relative percent change (%) in cancer incidence by cancer type (2019 vs 2020).

    Relative percent change (%) in cancer incidence by cancer type (2019 vs 2020). by Jinah Sim (15140709)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 128
    Forecasts of cancer patients’ medical use and expenditure (income/admission cases).

    Forecasts of cancer patients’ medical use and expenditure (income/admission cases). by Jinah Sim (15140709)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 129
    The effect of utilization due the characters of cancer patients (sex).

    The effect of utilization due the characters of cancer patients (sex). by Jinah Sim (15140709)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 130
    The effect of utilization due the characters of cancer patients (cancer type).

    The effect of utilization due the characters of cancer patients (cancer type). by Jinah Sim (15140709)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 131
    Forecasts of cancer patients’ medical use and expenditure (income/outpatient cases).

    Forecasts of cancer patients’ medical use and expenditure (income/outpatient cases). by Jinah Sim (15140709)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 132
    Additional loss of life expectancy and cost per life-year saved resulting from changes in colorectal cancer stage due to a 1-year diagnostic delay.

    Additional loss of life expectancy and cost per life-year saved resulting from changes in colorectal cancer stage due to a 1-year diagnostic delay. by Hiroaki Saito (24514)

    Published 2025
    Save to List
    Saved in:
  13. 133
    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 134
    Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  15. 135
    Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  16. 136
    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  17. 137
    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 138
    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 139
    S1 Dataset -

    S1 Dataset - by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  20. 140
    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: